T

TYBOURNE CAPITAL MANAGEMENT HK LTD Portfolio Analytics

Investment Analysis & Holdings Breakdown

Comprehensive portfolio analytics for TYBOURNE CAPITAL MANAGEMENT HK LTD with $30.9M in long positions as of Q3 2025, 82% allocated to Healthcare, and 100% concentrated in top 10 positions.

Portfolio Value
$30.9M
Top 10 Concentration
100%
Top Sector
Healthcare (82%)
US Exposure
100%
Market Cap Focus
Small Cap
Countries
1

Composition Analysis

Portfolio breakdown by sector, industry, and market capitalization

Sector Allocation

Healthcare: 82.00%Healthcare
Healthcare
82.00%

Industry Breakdown

1 industry across all sectors

Biotechnology: 81.95%Biotechnology
Biotechnology
Healthcare
81.95%

Filter by Sector

Select a sector to filter industries

Market Cap Distribution

Small Cap ($300M - $2B): 57.16%Small Cap ($300M - $2B)Micro Cap ($50M - $300M): 42.84%Micro Cap ($50M - $300M)
Small Cap ($300M - $2B)
57.16%
Micro Cap ($50M - $300M)
42.84%

Portfolio Concentration

Top 10 Holdings %
100.0%
Top 20 Holdings %
100.0%
Top 50 Holdings %
100.0%
Top 100 Holdings %
100.0%

Geographic Exposure

Portfolio breakdown by country of incorporation

Domestic (US)
100.0%
International
-
Countries
1
United States of America
100.00% ($30.9M)
4 holdings

Holding Behavior

Investment patterns and position management analysis

Portfolio Stability & Commitment

Avg. Top 10
12.5 quarters
Avg. Top 20
12.5 quarters
Avg. All Positions
12.5 quarters
Median Holding Period
14 quarters
Persistence Rate
75.0%
Persistent Holdings Weight
81.95%
Persistent Positions
3
Longest Held
Zentalis Pharmaceuticals, Inc. Common Stock logo
Zentalis Pharmaceuticals, Inc. Common StockZNTL - 21 quarters

Position Sizing & Influence

Current Quarter

Avg. New Position
0.000%
Avg. Position Weight
25.00%
Largest Position
Taysha Gene Therapies, Inc. Common Stock logo
Taysha Gene Therapies, Inc. Common StockTSHA - 39.11%
Largest Ownership Stake
Forte Biosciences, Inc. Common Stock logo
Forte Biosciences, Inc. Common StockFBRX - 6.33%
Avg. Ownership Stake
3.25%
Ownership Stake >5%
1
Ownership Stake >1%
4

Historical (Since Q2 2013)

Avg. New Position
4.59%
Avg. Ownership Stake
0.80%
Largest Position
Taysha Gene Therapies, Inc. Common Stock logo
Taysha Gene Therapies, Inc. Common StockTSHA - 39.11% (Q3 2025)
Largest Ownership Stake
Forte Biosciences, Inc. Common Stock logo
Forte Biosciences, Inc. Common StockFBRX - 11.95% (Q2 2025)

Portfolio Turnover

Current Quarter

Turnover Ratio
17.9%
Value Traded
$5.53M
Positions Added
0
Positions Exited
2

Historical (Since Q2 2013)

Avg. Turnover Ratio
39.4%
Avg. Positions Added
3
Avg. Positions Exited
3
Highest Turnover
751.4%
Q1 2025
Lowest Turnover
5.8%
Q2 2022

Cookie Preferences

We use cookies for analytics. See our Privacy and Cookie Policy.